Search

Your search keyword '"Sproviero, William"' showing total 208 results

Search Constraints

Start Over You searched for: Author "Sproviero, William" Remove constraint Author: "Sproviero, William"
208 results on '"Sproviero, William"'

Search Results

1. Whole-genome sequencing reveals that variants in the Interleukin 18 Receptor Accessory Protein 3′UTR protect against ALS

2. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.

4. Opioid use, postoperative complications, and implant survival after unicompartmental versus total knee replacement: a population-based network study

5. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

6. Interplay of Metabolome and Gut Microbiome in Individuals With Major Depressive Disorder vs Control Individuals

8. The impact of Short Tandem Repeats on grey matter brain imaging derived phenotypes in UK Biobank

10. Interplay of the human exposome, metabolome and gut microbiome in dementia and major depression

11. Comparative effect of metformin versus sulfonylureas with dementia and Parkinson’s disease risk in US patients over 50 with type 2 diabetes mellitus

12. Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort

13. The multistep hypothesis of ALS revisited: The role of genetic mutations

14. Interplay of Human Metabolome and Gut Microbiome in Major Depression

15. Genome wide association neural networks (GWANN) identify novel genes linked to family history of Alzheimer’s disease in the UK Biobank

16. Interplay of the human exposome, metabolome and gut microbiome in dementia and major depression

17. Comparative effect of metformin versus sulfonylureas with dementia and Parkinson's disease risk in US patients over 50 with type 2 diabetes mellitus

18. Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials

20. Longitudinal analysis of UK Biobank participants suggests age and APOE-dependent alterations of energy metabolism in development of dementia

21. ATXN2 trinucleotide repeat length correlates with risk of ALS

26. Genetic counselling in ALS: facts, uncertainties and clinical suggestions

28. ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization

29. Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression

30. Development and validation of patient-level prediction models for adverse outcomes following total knee arthroplasty

33. Genome-wide Meta-analysis Finds the ACSL5-ZDHHC6 Locus Is Associated with ALS and Links Weight Loss to the Disease Genetics

34. Additional file 1: of C9orf72 intermediate expansions of 24â 30 repeats are associated with ALS

35. Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeat

36. Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort

37. Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort

38. Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort

39. FUS mutations in sporadic amyotrophic lateral sclerosis: Clinical and genetic analysis

40. Identification of new risk factors for rolandic epilepsy:CNV at Xp22.31 and alterations at cholinergic synapses

41. Telomere length is greater in ALS than in controls: a whole genome sequencing study

42. ALSgeneScanner: a pipeline for the analysis and interpretation of DNA sequencing data of ALS patients

43. The multistep hypothesis of ALS revisited: The role of genetic mutations

44. Project MinE : study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis

45. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

46. Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis

47. Targeted genetic screen in amyotrophic lateral sclerosis reveals novel genetic variants with synergistic effect on clinical phenotype

48. Detection of long repeat expansions from PCR-free whole-genome sequence data

49. ALSgeneScanner: a pipeline for the analysis and interpretation of DNA NGS data of ALS patients

50. Identification of new risk factors for rolandic epilepsy: CNV at Xp22.31 and alterations at cholinergic synapses

Catalog

Books, media, physical & digital resources